Inhibitory effect of Embelin on human acute T cell lymphoma Jurkat cells through activation of the apoptotic pathway

Zhu,Xiu‑Li; Jiang,Lian; Qu,Fan; Wang,Zhi‑Yu; Zhao,Lian‑Mei

doi:10.3892/ol.2015.3364

Inhibitory effect of Embelin on human acute T cell lymphoma Jurkat cells through activation of the apoptotic pathway

Authors:
- Xiu‑Li Zhu
- Lian Jiang
- Fan Qu
- Zhi‑Yu Wang
- Lian‑Mei Zhao
View Affiliations

Affiliations: Department of Pediatrics, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China, Department of Immunology and Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China, Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: June 11, 2015 https://doi.org/10.3892/ol.2015.3364
Pages: 921-926

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has previously been shown that Embelin inhibits proliferation, promotes apoptosis, and increases sensitivity and reduces resistance to chemotherapy drugs, in various types of tumor cells. The present study examined the effects of Embelin on the proliferation of human acute T cell lymphoma Jurkat cells. Jurkat cells were treated with various concentrations of Embelin and the effects of Embelin on the inhibition of growth of Jurkat cells were evaluated. Expression of X‑linked inhibitor of apoptosis protein (XIAP); poly ADP ribose polymerase; caspase‑3; caspase‑8; caspase‑9; the proapoptotic protein, Bax; and the antiapoptotic proteins, Bcl‑xl and Bcl‑2, were assessed. The results showed that Embelin significantly inhibited the growth of human acute T cell lymphoma Jurkat cells. Following treatment with 5, 10 or 20 mM Embelin for 48 h, cell viability was 82.31, 58.65 and 37.62%, respectively, which was significantly reduced compared with that of the control group and the 0.1% DMSO control group (P<0.01). Furthermore, the caspase‑3 inhibitor, z‑DEVD‑fmk, and the caspase‑9 inhibitor, Ac‑LEHD‑CHO, reversed this inhibitory effect. It was also shown that the apoptotic rate of cells treated with Embelin was significantly elevated. Subsequently, it was demonstrated that Embelin downregulated the expression of XIAP and the proapoptotic Bcl2 family members, Bcl‑2 and Bcl‑xl, while it concomitantly upregulated that of the antiapoptotic protein, Bax. These results showed that Embelin inhibited growth and induced apoptosis of Jurkat cells in vitro, by activating the endogenous caspase‑dependent apoptotic pathway through inhibition of XIAP and proapoptotic Bcl‑2 family members.

View Figures

View References

1	Andrade AF, Borges KS, Castro-Gamero AM, Silveira VS, Suazo VK, Oliveira JC, Moreno DA, de Paula Queiroz RG, Scrideli CA and Tone LG: Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells. Anticancer Drugs. 25:72–81. 2014. View Article : Google Scholar : PubMed/NCBI
2	Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, et al: Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. N Engl J Med. 369:1681–1690. 2013. View Article : Google Scholar : PubMed/NCBI
3	Plosker GL and Figgitt DP: A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs. 63:803–843. 2003. View Article : Google Scholar : PubMed/NCBI
4	Till KJ, Coupland SE and Pettitt AR: Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review). Int J Oncol. 45:5–12. 2014.PubMed/NCBI
5	Moreno-Martínez D, Nomdedeu M, Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, Díaz-Beyá M, Rozman M, Montserrat E, Urbano-Ispizua A, et al: XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells. Oncotarget. 12:4337–4346. 2014.
6	Wang A, Zhang B, Zhang J and Wu W and Wu W: Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway. Oncol Rep. 29:2473–2478. 2013.PubMed/NCBI
7	Dai Y, Jiao H, Teng G, Wang W, Zhang R, Wang Y, Hebbard L, George J and Qiao L: Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther. 13:1206–1216. 2014. View Article : Google Scholar : PubMed/NCBI
8	Yao GH, Luan JF, Ye D, Yan JM, Lei QH, Zhu PY and Jin J: Effects of triptolide on proliferation and apoptosis of Jurkat cell line in acute T lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 16:506–509. 2008.(In Chinese). PubMed/NCBI
9	Hu R, Wu B, Zhang GJ, Wang HT, Zhu K, Yang W and Liu ZG: Effect of Embelin on proliferation, differentiation and apoptosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi. 31:442–445. 2010.(In Chinese). PubMed/NCBI
10	Marsh JL, Jackman CP, Tang SN, Shankar S and Srivastava RK: Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment. Front Biosci (Landmark Ed). 19:113–125. 2014. View Article : Google Scholar : PubMed/NCBI
11	Cheng YJ1, Jiang HS, Hsu SL, Lin LC, Wu CL, Ghanta VK and Hsueh CM: XIAP-mediated protection of H460 lung cancer cells against cisplatin. Eur J Pharmacol. 627:75–84. 2010. View Article : Google Scholar : PubMed/NCBI
12	Deveraux QL, Takahashi R, Salvesen GS and Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300–304. 1997. View Article : Google Scholar : PubMed/NCBI
13	Zhao L, Shan B, Du Y, Wang M, Liu L and Ren FZ: Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep. 24:375–383. 2010.PubMed/NCBI
14	Danial NN: Bcl-2 family proteins: Critical checkpoints of apoptotic cell death. Clin Cancer Res. 13:7254–7263. 2007. View Article : Google Scholar : PubMed/NCBI
15	Silke J and Vucic D: IAP family of cell death and signaling regulators. Methods Enzymol. 545:35–65. 2014. View Article : Google Scholar : PubMed/NCBI
16	Kuwana T and Newmeyer DD: Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI
17	Bao W, Zhu F, Duan Y, Yang Y and Cai H: HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP. Biomed Pharmacother. 70:97–102. 2015. View Article : Google Scholar : PubMed/NCBI
18	Chen FH, Qu HY and Sui GJ: Effects of apoptosis protein XIAP inhibito on the apoptosis and sensitivity of chemotherapy in A549 cell. Chin J Lung Cancer. 11:368–372. 2008.(In Chinese).
19	Nikolovska-Coleska Z, Xu L, Hu Z, et al: Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 47:2430–2440. 2004. View Article : Google Scholar : PubMed/NCBI
20	Irshad S, Ashworth A and Tutt A: Therapeutic potential of PARP inhibitors for metastatic breast cancer. Expert Rev Anticancer Ther. 11:1243–1251. 2011. View Article : Google Scholar : PubMed/NCBI
21	Nikrad M, Johnson T, Puthalalath H, Coultas L, Adams J and Kraft AS: The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Mol Cancer Ther. 4:443–449. 2005.PubMed/NCBI
22	Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
23	Ulukaya E, Acilan C and Yilmaz Y: Apoptosis: Why and how does it occur in biology. Cell Biochem Funct. 29:468–480. 2011. View Article : Google Scholar : PubMed/NCBI